suloctidil has been researched along with Arterial-Occlusive-Diseases* in 7 studies
1 review(s) available for suloctidil and Arterial-Occlusive-Diseases
| Article | Year |
|---|---|
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets; Catheterization; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Glomerulonephritis; Humans; Sulfinpyrazone; Suloctidil; Thiophenes; Thrombophlebitis; Thrombosis; Ticlopidine; Vascular Diseases; Vascular Surgical Procedures | 1986 |
3 trial(s) available for suloctidil and Arterial-Occlusive-Diseases
| Article | Year |
|---|---|
Combination of suloctidil and anticoagulation in the prevention of reocclusion after femoro-popliteal PTA.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Female; Femoral Artery; Humans; Male; Middle Aged; Popliteal Artery; Propanolamines; Random Allocation; Recurrence; Suloctidil | 1987 |
[Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Humans; Intermittent Claudication; Leg; Male; Middle Aged; Propanolamines; Random Allocation; Suloctidil; Theophylline; Time Factors; Xanthinol Niacinate | 1983 |
[Clinical and instrumental evaluation of patients with chronic peripheral arterial occlusive disease after prolonged administration of suloctidil].
Topics: Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Oscillometry; Plethysmography; Plethysmography, Impedance; Propanolamines; Suloctidil | 1982 |
3 other study(ies) available for suloctidil and Arterial-Occlusive-Diseases
| Article | Year |
|---|---|
[Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
In 17 patients affected by atherosclerotic vascular disease and showing in basal conditions a hyperviscosity state, we have monitored the main hemorheological determinants during treatment with Suloctidil. At the end of treatment carried out for 5 months the results showed that erythrocyte filterability was the only hemorheological determinant influenced. The possible causes of this action are therefore considered. Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Intracranial Arteriosclerosis; Leg; Male; Middle Aged; Propanolamines; Rheology; Suloctidil | 1983 |
[A new preparation for peripheral arterial occlusive diseases].
Topics: Arterial Occlusive Diseases; Humans; Intermittent Claudication; Propanolamines; Suloctidil | 1982 |
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Aspirin; Benzophenones; Carotid Arteries; Cattle; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Imidazoles; Indoles; Indomethacin; Lung Diseases, Obstructive; Male; Mice; Platelet Aggregation; Prostaglandins; Pyridines; Quinazolines; Rats; Sulfinpyrazone; Sulfonamides; Suloctidil; Thiophenes | 1979 |